Dansey Roger D's Form 4 filing
Seagen Inc. (SGEN) · filed Aug 13, 2021
- Accession no.
- 0001203311-21-000053
- Filed
- Aug 13, 2021
- Trade date
- Aug 13, 2021
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $1.57M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dansey Roger DCIK 0001741836 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2021 | Common Stock | SSaleDisposed | −9,900 | $156.58F1 | −$1,550,142 | 74,535 | Direct | |
| Aug 13, 2021 | Common Stock | SSaleDisposed | −100 | $157.25 | −$15,725 | 74,435 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Reflects sales of common stock executed in multiple transactions at prices ranging from $156.25 to $157.23 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Referenced by the price of 1 transaction in Table I.